RFID Chip: 25 Alzheimer's Patients And Caregivers Receive VeriMed RFID Implantable Microchip At Alzheimer's Educational Conference
VeriChip Corporation, a provider of RFID systems for healthcare and patient-related needs, announced recently that 25 Alzheimer's conference attendees, including patients and caregivers received the VeriMed RFID implantable microchip at the Alzheimer's Community Care (ACC) 2007 Alzheimer's Educational Conference in West Palm Beach, Florida on June 7-8. Those who elected to receive the microchip are not part of VeriChip's previously announced collaboration with ACC.
"We have always believed that the Alzheimer's patient population is an important, at-risk group who could benefit from the VeriMed Patient Identification System," said Scott R. Silverman, Chairman and CEO of VeriChip Corporation. "Until recently, however, we did not fully understand the value of the VeriMed system for the caregivers of Alzheimer's patients. By providing medical personnel quick access to identification and medical records information in an emergency situation, that caregiver is simultaneously informing medical personnel that he or she is responsible for someone unable to care for themselves."
Enrollment for VeriChip's collaboration with ACC – a voluntary, two-year, 200 patient project to study the effectiveness of the VeriMed Patient Identification System in managing the records of Alzheimer's patients and their caregivers – is scheduled to commence this month. "We believe this most recent ACC event is only the beginning of a very productive relationship between VeriChip and ACC," said Silverman.
About VeriChip
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. Through its subsidiary, Xmark Corporation, the Company sells active RFID systems for local-area location and identification purposes. In addition, VeriChip recently began marketing its VeriMed Patient Identification System, a passive RFID system for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip, cleared for medical use in October 2004 by the United States Food and Drug Administration.
VeriChip Corporation is majority-owned by Applied Digital Solutions Inc., which also owns a majority position in Digital Angel Corporation. For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at www.verichipcorp.com.
SOURCE: VeriChip Corporation